WESTBOROUGH, MA, Jan 19, 2011 (MARKETWIRE via COMTEX) --
PharmaVigilant, a clinical trial technology provider, today announced the availability of I-Warehouse 3.0, an enhanced version of the company's unprecedented clinical data warehouse. The state-of-the-art system gives companies an innovative technology solution that provides immediate and ubiquitous access to study data with comparable results.
With I-Warehouse 3.0, the user interface has been redesigned to address the increasingly complex clinical trial environment. New features and functionality now streamline reporting to accommodate even more complex queries across multiple trials, and provides clients with access to their data at their fingertips. I-Warehouse offers superior organization of search criteria and a more streamlined selection process with drag and drop features, pre-populated mathematical calculations, and one-click results in the form of data on demand. Additionally, descriptive graphical summaries render visual components for study data results and report comparisons.
"I-Warehouse 3.0 was specifically redesigned in response to client feedback to provide a more user-friendly system for running reports and tracking study data," says James DeSanti, Founder and CEO, PharmaVigilant. "With this redesign, we are empowering customers to significantly expand their ability to meet the increased regulatory and safety challenges facing the industry. I-Warehouse now offers unprecedented access to all data from trials running on our InSpire EDC solution. This gives our clients even more control and flexibility with their data."
Additional unparalleled features of I-Warehouse 3.0 include:
-- Data on demand
-- Import utility enabling competitive datasets to be incorporated into
I-Warehouse
-- Excel and PDF exports
-- Customized charts and graphs
-- Report regeneration
-- Saved search criteria
PharmaVigilant offers a full suite of clinical trial technology offerings including: Electronic Data Capture (InSpire); study building (I-Builder 2.0); Electronic Trial Master File System (I-Vault); Remote Source Document Verification (rSDV); study administration; and an automated site payment system (PaySite). PharmaVigilant focuses on Phase I-IV clinical trials, registries and other post-marketing studies. The technology has supported more than 200,000 patients in 18 countries across North America, South America, and Asia and continues to expand rapidly.
About PharmaVigilant: Based in Westborough, Mass., PharmaVigilant is a SaaS company founded in 2005 to provide broader technologies to streamline the clinical trial process for biopharmaceutical companies. Its full suite of patient-based technology automates the collection, management and analysis of clinical trial data and most importantly puts that data in the sponsors' hands when and how they want it. Sponsors rely on PharmaVigilant to ease the regulatory and FDA submission and approval process and ultimately go-to market more quickly with top quality drugs. For more information, visit www.pharmavigilant.com.